affordable glp 1 injections GoodRx, Novo Nordisk team to make GLP-1 meds The Latest on GLP-1s |

First, these data reflect prescribing patterns only through July 2025 and may not capture whether the trends persist over a longer period following the formulary change

Their strategy seems to rely on their established brand and technological efficiency rather than community engagement or offering the most competitive pricing, making them a decent but not standout choice in a crowded market

Figure 1 GLP-1 RAs also gain access to hindbrain sites indirectly via the vagus nerve

Or are they going to be on them for the rest of their lives

Yes, generally

These medications are particularly beneficial for those who may not be candidates for surgery or prefer a less invasive approach